Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t...See more
Headquarter Denmark |
Year founded 1994 (30 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Corporate Vice President South East Asia Operations
Corporate Vice President
Vice President
The company has corporate shareholder(s) or more than 20 individual shareholders
The company is owned by individual shareholder(s), it has no corporate shareholder.
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
Auditor: | DELOITTE & TOUCHE LLP |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 25 Mar 1994 | Singapore | SGD 12,000,000 | 64201: BANK/FINANCIAL HOLDING COMPANIES (INCLUDING INSURANCE HOLDING COMPANY) |
| 4 Jun 1997 | Singapore | SGD 2,200,000 | 46461: WHOLESALE OF MEDICINAL AND PHARMACEUTICAL PRODUCTS (WESTERN) |
| 1 Oct 2021 | Singapore | SGD 10,000 | 46900: WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT |